BioRegenx Inc BRGX

Communication Services

BioRegenx, Inc., formerly Findit, Inc., operates as a holding company. The Company specializes in acquiring intellectual property (IP) and companies engaged in regenerative biotherapeutics and anti-aging research. Its primary focus involves acquiring and developing non-invasive medical and wellness devices capable of efficiently recording, storing, and analyzing datasets. The Company’s patented technologies and solutions include GlycoCheck, a high-definition video imaging that analyzes five parameters of microvascular health non-invasively with an under the tongue test using patented technology; Endocalyx Pro, an all-natural, plant-based patented nutraceutical shown to restore, regenerate, and protect microvascular health. Clinically tested in multiple double-blind placebo studies, and DocSun, an artificial intelligence using three advanced facial recognition technologies that analyzes 21 vital signs and health indicators without physical contact.

OTCPK:BRGX - Post by User

BioRegenx Inc

Bullboard Posts

Next >>

Post by UptickSocialon Jul 19, 2018 2:14pm

37 Views

Post# 28340061

FDIT

$FDIT New Press Release ~ Findit, Inc. Engages Uptick Newswire for Corporate Communications Services to Increase Service Offerings for Clients https://goo.gl/c9sbDT

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market